| Entry |
|
|---|
| Name |
Vebreltinib (USAN) |
|---|
| Formula |
C20H15F3N8
|
|---|
| Exact mass |
424.1372
|
|---|
| Mol weight |
424.38
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
|---|
| Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D12053 Vebreltinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
MET family
MET* [HSA_VAR:4233v4]
D12053 Vebreltinib (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 31
1 C8x C 13.3700 -14.0000
2 C8y C 13.3700 -15.4000
3 N5x N 14.5600 -16.1000
4 N4y N 15.8200 -15.4000
5 C8y C 15.8200 -14.0000
6 C8x C 14.5600 -13.3000
7 C8y C 17.1500 -15.8200
8 N5x N 17.9200 -14.7000
9 N5x N 17.1500 -13.5800
10 C8y C 12.1800 -16.1000
11 C8x C 11.0600 -15.3300
12 N4y N 9.8700 -16.2400
13 N5x N 10.3600 -17.5000
14 C8x C 11.8300 -17.4300
15 C1y C 8.5400 -15.7500
16 C1d C 17.6400 -17.1500
17 C8y C 19.0400 -17.4300
18 X F 16.7300 -18.2000
19 X F 16.2400 -16.8700
20 C8y C 19.4600 -18.7600
21 C8x C 20.8600 -19.0400
22 C8y C 21.7700 -17.9900
23 C8y C 21.2800 -16.6600
24 C8x C 19.9500 -16.3800
25 N5x N 23.1700 -17.9200
26 N4y N 23.5900 -16.5900
27 C8x C 22.4700 -15.7500
28 X F 18.5500 -19.8100
29 C1a C 24.9200 -16.1700
30 C1x C 7.1400 -15.7500
31 C1x C 7.8400 -14.5600
BOND 36
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 2
11 2 10 1
12 10 11 2
13 11 12 1
14 12 13 1
15 13 14 2
16 10 14 1
17 12 15 1
18 7 16 1
19 16 17 1
20 16 18 1
21 16 19 1
22 17 20 1
23 20 21 2
24 21 22 1
25 22 23 1
26 23 24 1
27 17 24 2
28 22 25 2
29 25 26 1
30 26 27 1
31 23 27 2
32 20 28 1
33 26 29 1
34 30 15 1
35 15 31 1
36 31 30 1
|
|---|
